Impact of an Online Risk Calculator for Sentinel Node Positivity on Management of Patients with T1 and T2 Melanomas

Alec A. Winder; Zoe Boyer; Sydney Ch’ng; Jonathan R. Stretch; Robyn P.M. Saw; Kerwin F. Shannon; Thomas E. Pennington; Omgo E. Nieweg; Alexander H. R. Varey; Richard A Scolyer; John F. Thompson; Anne Ε. Cust; Serigne Lo; Andrew J. Spillane; Andrea L. Smith

doi:10.1245/s10434-024-15456-w

Abstract

1 min read

In this specialized center, the SLN risk calculator appears to influence practice for melanomas previously considered low risk for metastasis, with increased use of SLNB for T1a and higher-risk T1b melanomas. Further evaluation is required across broader practice settings. Melanoma management guidelines could be updated to incorporate the availability of nomograms to better select patients for SLNB than previous criteria.

Related publications

Article2023

Population-based validation of the melanoma institute australia (MIA) and the memorial sloan-kettering cancer center (MSKCC) predictive tool for sentinel node status in patients with melanoma.

Rasmus Mikiver, Roger Olofsson Bagge, Michael A. Marchetti, Alexander Christopher Jonathan Van Akkooi, Daniel G. Coit, Christian Ingvar, Karolin Isaksson, Richard A Scolyer, John F. Thompson, Alexander H. R. Varey, Johan Lyth, Edmund K. Bartlett

Article2018

Sentinel lymph node biopsy in patients with thin melanomas: Frequency and predictors of metastasis based on analysis of two large international cohorts

Karolin Isaksson, K. Nielsen, Rasmus Mikiver, Omgo E. Nieweg, Richard A Scolyer, John F. Thompson, Christian Ingvar

Article2020

Improved Risk Prediction Calculator for Sentinel Node Positivity in Patients With Melanoma: The Melanoma Institute Australia Nomogram

Serigne Lo, Jiawen Ma, Richard A Scolyer, Lauren E. Haydu, Jonathan R. Stretch, Robyn P.M. Saw, Omgo E. Nieweg, Kerwin F. Shannon, Andrew J. Spillane, Sydney Ch’ng, Graham J. Mann, Jeffrey E. Gershenwald, John F. Thompson, Alexander H. R. Varey

Article2024

Predicting sentinel node positivity in patients with primary cutaneous melanoma: an international multicentre study validating and refining the MIA risk calculator

Alexander H. R. Varey, Caroline A. Gjorup, Annette H. Chakera, L. Rosenkrantz Hölmich, Marc Moncrieff, Alastair D. MacKenzie Ross, Oliver Cassell, Jianhua Ma, Marie Brinch-Møller Weitemeyer, Roger Olofsson Bagge, Siri Klausen, Vinícius F. Calsavara, João Pedreira Duprat Neto, Eduardo Bertolli, Sydney Ch’ng, Robyn P.M. Saw, Kerwin F. Shannon, Andrew J. Spillane, Omgo E. Nieweg, Jonathan R. Stretch, G.J. Mann, Jenny L. C. Geh,

Article2022

Sentinel lymph node biopsy rates in Victoria, 2018 and 2019

Caroline G. Watts, Andrew J. Spillane, Michael A. Henderson, Anne Ε. Cust, Jeffrey Braithwaite, DE Gyorki, AM Hong, Kelly Jw, GV Long, VJ Mar, AM Menzies, Rachael L. Morton, Frances Rapport, Rpm Saw, Helen Schmid, Richard A Scolyer, Al Smith, Abigail Winder, GJ Mann